VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BigKNY3 who wrote (20187)	3/31/1999 9:24:00 AM
From: Mkilloran	Read Replies (1) of 23519

BigKNY3...thanks for the March 1st research report by Paine Webber that announced the approval of Muse in Germany and triggered $2 mill milestone payment. However a lot has happened since March 1st... France approved Muse and triggered an additional $2 mill milestone payment. Norway, Austria and Portugal approved Muse. Vivue received two patents...one for Female Sexual dysfunction and another for Alibra treatment of ED in men. Two new board members have been added to Vivus's board: Mark Logan the CEO of Visx Mario Rosati...partner in law firm of Wilson,Sonsini,Goodrich and Rosati. Let's see if PaineWebber issues an updated research report after the Vivus conf call in 3 weeks.........

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next